FdaApplication
ANDA 203817
Identifiers
- fda_app_no: ANDA203817
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2018-03-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MESALAMINE | MESALAMINE | 1.2GM | TABLET, DELAYED RELEASE;ORAL |
1 product